Try the modernized beta website. Learn more about the modernization effort.

Key Record Dates Identifier: NCT04660539
Brief Title: A Study to Evaluate the Safety and Efficacy of Satralizumab in Participants With Neuromyelitis Optica Spectrum Disorder (NMOSD)

First Submitted : November 24, 2020
First Submitted that Met QC Criteria : December 7, 2020
First Posted : December 9, 2020

Last Update Submitted that Met QC Criteria : January 10, 2022
Last Update Posted : January 11, 2022